All Stories

  1. Mounting evidence indicates that escalating doses of allopurinol are unnecessary for cardiovascular protection: comment on the article by Coburn et al

    Article • Arthritis & Rheumatology, August 2018, Wiley

    Dr Markus Bredemeier

  2. Reply

    Article • Arthritis Care & Research, September 2014, Wiley

    Dr Markus Bredemeier

  3. FRI0494 Long-Term Effectiveness and Safety of Cyclophosphamide in Systemic Sclerosis Lung Disease

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Markus Bredemeier

  4. Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vitalet al

    Article • Annals of the Rheumatic Diseases, March 2014, BMJ

    Dr Markus Bredemeier

  5. Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Article • Arthritis Care & Research, January 2014, Wiley

    Dr Markus Bredemeier

  6. Assessment of nailfold capillaroscopy in systemic sclerosis by different optical magnification methods

    Article • Clinical and Experimental Dermatology, December 2013, Wiley

    Dr Markus Bredemeier

  7. AB0505 Case report of allogeneic unrelated-donor mesenchymal stem cells (msc) infusion in systemic sclerosis (ssc)

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Markus Bredemeier

  8. Interleukin-10 Gene Promoter and NFKB1 Promoter Insertion/Deletion Polymorphisms in Systemic Sclerosis

    Article • Scandinavian Journal of Immunology, January 2013, Wiley

    Dr Markus Bredemeier

  9. Characteristics of NK cell activity in patients with systemic sclerosis

    Article • Revista Brasileira de Reumatologia (English Edition), January 2013, Elsevier

    Dr Markus Bredemeier

  10. Características de atividade das células natural killer em pacientes com esclerose sistêmica

    Article • Revista Brasileira de Reumatologia, January 2013, Elsevier

    Dr Markus Bredemeier

  11. Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis

    Article • Cytokine, November 2012, Elsevier

    Dr Markus Bredemeier

  12. Last observation carried forward approach threatens the validity of intent-to-treat analysis in fibromyalgia trials: Comment on the article by Arnold et al

    Article • Arthritis & Rheumatism, July 2012, Wiley

    Dr Markus Bredemeier

  13. Impact on the Quality of Life of an Educational Program for the Prevention of Work-Related Musculoskeletal Disorders: a randomized controlled trial

    Article • BMC Public Health, January 2011, Springer Science + Business Media

    Dr Markus Bredemeier

  14. A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: Comment on the article by Seibold et al

    Article • Arthritis & Rheumatism, July 2010, Wiley

    Dr Markus Bredemeier

  15. NT-proBNP levels in systemic sclerosis: Association with clinical and laboratory abnormalities

    Article • Clinical Biochemistry, June 2010, Elsevier

    Dr Markus Bredemeier

  16. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis

    Article • Clinical & Experimental Immunology, January 2010, Wiley

    Dr Markus Bredemeier

  17. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis

    Article • Arthritis & Rheumatism, June 2009, Wiley

    Dr Markus Bredemeier

  18. Glu298Asp eNOS polymorphism is not associated with SLE

    Article • Lupus, April 2009, SAGE Publications

    Dr Markus Bredemeier

  19. Intraorbital Polyacrylamide Gel Injection for the Treatment of Anophthalmic Enophthalmos

    Article • Ophthalmic Plastic and Reconstructive Surgery, September 2008, Wolters Kluwer Health

    Dr Markus Bredemeier

  20. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients

    Article • Scandinavian Journal of Rheumatology, January 2007, Taylor & Francis

    Dr Markus Bredemeier

  21. Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy

    Article • British Journal of Radiology, September 2006, British Institute of Radiology

    Dr Markus Bredemeier

  22. Impacto da atividade inflamatória e uso de glicocorticóide nas variáveis nutricionais da artrite idiopática juvenil

    Article • Revista Brasileira de Reumatologia, October 2005, Elsevier

    Dr Markus Bredemeier

  23. Capilaroscopia periungueal pode sugerir atividade de doença pulmonar na esclerose sistêmica

    Article • Revista Brasileira de Reumatologia, February 2004, Elsevier

    Dr Markus Bredemeier

  24. A Study of the Association Between Epistaxis and the Severity of Hypertension

    Article • American Journal of Rhinology and Allergy, July 1998, Oceanside Publications Inc.

    Dr Markus Bredemeier

  25. Alcohol intake and blood pressure

    Article • Journal of Hypertension, February 1998, Wolters Kluwer Health

    Dr Markus Bredemeier

  26. Alcoholic beverage consumption and associated factors in Porto Alegre, a southern Brazilian city: a population-based survey.

    Article • Journal of Studies on Alcohol, May 1996, Alcohol Research Documentation, Inc.

    Dr Markus Bredemeier

  27. Prevalência de tabagismo e fatores associados em área metropolitana da região Sul do Brasil

    Article • Revista de Saúde Pública, February 1995, FapUNIFESP (SciELO)

    Dr Markus Bredemeier